Fred Rosenberg
Gastroenterology · Gurnee, ILNPI 1003817180
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,190 of the $2,564 with a category attached, or 85.4%. 24 manufacturers reported payments, led by AbbVie at 25.0% of the total. Reporting peaked in 2022 at $817 and has fallen 89.5% since, to $86 in 2025.
Across 184 payments — averaging $13.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$642
- Johnson & Johnson$594
- Takeda Pharmaceuticals U.S.A., Inc.$312
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$212
- Gilead$197
- Redhill Biopharma Inc.$113
- plus $494 from 18 others
Across 96 payments — averaging $3285.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$172K
- Shire North American Group Inc$76K
- Ironwood Pharmaceuticals, Inc$66K
- Pfizer$910
What the payments were for
- Speaking & faculty fees$1084%
- Food & beverage$2,19085%
- Education$26610%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 46 | $642 |
| Johnson & Johnson(2 entities) | 39 | $594 |
| Takeda Pharmaceuticals U.S.A., Inc. | 33 | $312 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $212 |
| Gilead | 14 | $197 |
| Redhill Biopharma Inc. | 3 | $113 |
| Pfizer | 4 | $73 |
| QOL Medical, LLC | 7 | $52 |
| Merck | 3 | $44 |
| Intercept Pharmaceuticals, Inc. | 3 | $40 |
| Boston Scientific | 1 | $39 |
| Daiichi Sankyo Inc. | 2 | $38 |
| UCB, Inc. | 1 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Bristol Myers Squibb | 2 | $28 |
| Alfasigma USA, Inc. | 1 | $21 |
| Shionogi Inc | 1 | $18 |
| Sanofi | 1 | $17 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Medtronic | 1 | $12 |
| W. L. Gore & Associates, Inc. | 1 | $11 |
| Organon | 1 | $7 |
| Romark Laboratories, LC | 1 | $7 |
| Vivus LLC | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rinvoq$108
How this compares
$2,564 in reported general payments places this provider in the 60th percentile of 787 gastroenterology providers in Illinois.
Other gastroenterology in Gurnee
- Jonathan RosenbergGurnee$1M
- David RubinChicago$1.5M
- Stephen HanauerChicago$1.4M
- Steven FlammChicago$1.3M
- Amar NaikDes Plaines$1.2M
- Darren BrennerChicago$1.1M
- Daksesh PatelEvanston$745K
- Russell CohenChicago$690K
- Parambir DulaiChicago$668K
- Christopher ChapmanChicago$645K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.